Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Diagnostic and Prognostic Research|May 17, 2019
A PCR-based diagnostic testing strategy to identify carbapenemase-producing Enterobacteriaceae carriers upon admission to UK hospitals: early economic modelling to assess costs and consequencesEoin Moloney, Kai Wai Lee, Dawn Craig, et al.Pharmacoeconomics - Open|October 18, 2022
Psychometric Validation of the Growth Hormone Deficiency-Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency-Parent Treatment Burden Measure (GHD-PTB)Meryl Brod, Michael Højby Rasmussen, Suzanne Alolga, et al.The Lancet. Rheumatology|May 5, 2025
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trialVibeke Strand, Kenneth C Kalunian, Kai Wai Lee, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 14, 2026
Modeling SLE Treatment Cost-Effectiveness Based on a Novel LLDAS Treat-to-Target ApproachMaria Farris, Jenna Christensen, Vera Golder, et al.Rheumatology (Oxford, England)|November 11, 2025
Disease progression in patients with systemic lupus erythematosus: an analysis of the SLE Prospective Observational Cohort Study (SPOCS)Eric F Morand, Richard Furie, Martin Aringer, et al.Pageof 1